wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37489324-85547DD7-B01D-4CA9-8907-1555E29D5AE9
Q37489324-85547DD7-B01D-4CA9-8907-1555E29D5AE9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37489324-85547DD7-B01D-4CA9-8907-1555E29D5AE9
Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatme
P2860
Q37489324-85547DD7-B01D-4CA9-8907-1555E29D5AE9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37489324-85547DD7-B01D-4CA9-8907-1555E29D5AE9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
27e84b14ec6ed281ec7f950691f936d009626e02
P2860
The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults.